Dr Hughes on Efficacy Data for Asciminib in Newly Diagnosed Ph+ CP-CML
Nivolumab/Cabozantinib Combination Prolongs Treatment-Free Survival in Advanced RCC
High CR Rate in NMIBC Is Maintained by Cretostimogene Grenadenorepvec Plus Pembrolizumab
Intensification With Apalutamide/ADT Improves PSA PFS in Biochemically Recurrent Prostate Cancer